HEPARIN CLASS ACTION
Illinois class action blames deaths on heparin manufacturer's quest for profits
March 4, 2009 -- A group of people whose spouses have died from heparin, a blood thinner that was recalled last year due to contamination at its source in China, have filed a class action lawsuit against its manufacturer, Baxter International Inc.
According to the complaint, filed in St. Clair (Ill.) County Circuit Court on Feb. 23, a group of 28 people are charging that Baxter began substituting a more dangerous ingredient to “reap greater profits as a result of utilizing cheap component parts.”
Heparin class action
Heparin is one of the nation’s most popular blood-thinners, and is used to prevent blood clots in millions of people with heart conditions or who are undergoing surgery.
Since last year’s recall, U.S. scientists have proposed new heparin testing standards for the blood-thinner after hundreds of deaths were linked to tainted Chinese ingredients.
Prior to last year’s recall, Deerfield, Illinois-based Baxter made about half of the injectable heparin used in the United States, generating about $30 million a year in sales.
Weitz & Luxenberg, P.C.
If you were harmed after being administered heparin, or by any prescribed pharmaceutical drug, you are urged to complete the form on this page for a free legal review of your rights to receive financial compensation.
Click To Talk To Us Online
Joint Commission on Hospital Heparin Rules 
Joint Commission's recomends rules for hospitals to monitor Heparin
Healthcare commission mandates for strict Heparin hospital rules
Heparin Blood Thinner Did Contamination of Heparin Blood Thinner Occur in US or China?
FDA Investigates If Heparin Blood Thinner Contamination Was Deliberate
Heparin News Breaking News: Baxter Recalls Most Heparin Products After 4 Die
Heparin Pulled From Market After News of Illness--Free Lawsuit Info
